Aminoglycosides: do we need new agents?
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D009355:Neomycin; D013307:Streptomycin; D014031:Tobramycin / Q000009:adverse effects / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D009355:Neomycin; D014031:Tobramycin; D013307:Streptomycin